(19)
(11) EP 1 776 095 A1

(12)

(43) Date of publication:
25.04.2007 Bulletin 2007/17

(21) Application number: 05766754.5

(22) Date of filing: 22.06.2005
(51) International Patent Classification (IPC): 
A61K 31/00(2006.01)
A61K 31/55(2006.01)
A61K 31/4184(2006.01)
A61P 9/12(2006.01)
 A61K 45/06(2006.01)
A61K 31/4178(2006.01)
A61P 9/00(2006.01)
(86) International application number:
PCT/EP2005/052915
(87) International publication number:
WO 2006/000564 (05.01.2006 Gazette 2006/01)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 23.06.2004 EP 04102906
23.06.2004 US 581723 P

(71) Applicant: Solvay Pharmaceuticals GmbH
30173 Hannover (DE)

(72) Inventors:
  • ZIEGLER, Dieter
    30966 Hemmingen (DE)
  • WITTE, Klaus
    30171 Hannover (DE)
  • STRAUB, Matthias
    30890 Barsinghausen (DE)
  • FISCHER, Yvan
    30890 Barsinghausen (DE)
  • THORMAEHLEN, Dirk
    31039 Rheden (DE)
  • HOELTJE, Dagmar
    30989 Gehrden (DE)

(74) Representative: Bauriegel, Lutz 
c/o Solvay Pharmaceuticals GmbH, PH-ZP (IPSI), Hans-Böckler-Allee 20
30173 Hannover
30173 Hannover (DE)

   


(54) PHARMACEUTICAL COMPOSITIONS COMPRISING NEP-INHIBITORS, INHIBITORS OF THE ENDOGENOUS ENDOTHELIN PRODUCING SYSTEM AND AT1-RECEPTOR ANTAGONISTS